Published in J Virol on March 01, 1992
SURVEY AND SUMMARY: holliday junction resolvases and related nucleases: identification of new families, phyletic distribution and evolutionary trajectories. Nucleic Acids Res (2000) 3.56
Bacterial-type DNA holliday junction resolvases in eukaryotic viruses. Proc Natl Acad Sci U S A (2000) 1.71
Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes. J Virol (2001) 1.39
Escherichia coli with a linear genome. EMBO Rep (2007) 1.16
Characterization of a Holliday junction-resolving enzyme from Schizosaccharomyces pombe. Mol Cell Biol (1997) 1.09
Resolving the relationships of resolving enzymes. Proc Natl Acad Sci U S A (2000) 1.08
Vaccinia virus nicking-joining enzyme is encoded by K4L (VACWR035). J Virol (2005) 0.86
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A (1982) 7.81
The complete DNA sequence of vaccinia virus. Virology (1990) 7.76
Genetic Structure of Bacteriophage T4 as Described by Recombination Studies of Factors Influencing Plaque Morphology. Genetics (1953) 6.90
Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA. Proc Natl Acad Sci U S A (1982) 5.25
T4 endonuclease VII cleaves holliday structures. Cell (1982) 3.47
Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology (1981) 3.43
Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA. J Mol Biol (1974) 3.20
Molecular genetics of vaccinia virus: demonstration of marker rescue. Proc Natl Acad Sci U S A (1982) 3.01
The DNA enzymology of protein machines. Cold Spring Harb Symp Quant Biol (1984) 2.66
Two deoxyribonuclease activities within purified vaccinia virus. Proc Natl Acad Sci U S A (1969) 2.46
Mapping and identification of the vaccinia virus thymidine kinase gene. J Virol (1982) 2.44
The mechanism of cytoplasmic orthopoxvirus DNA replication. Cell (1981) 2.16
Replication of vaccinia virus DNA in enucleated L-cells. J Mol Biol (1971) 2.04
Gene 3 endonuclease of bacteriophage T7 resolves conformationally branched structures in double-stranded DNA. J Mol Biol (1987) 1.87
Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci U S A (1987) 1.80
Partial purification of an enzyme from Saccharomyces cerevisiae that cleaves Holliday junctions. Proc Natl Acad Sci U S A (1985) 1.76
Resolution of vaccinia virus DNA concatemer junctions requires late-gene expression. J Virol (1989) 1.68
Cleavage of cruciform DNA structures by an activity from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1985) 1.64
Mapping of the vaccinia virus DNA polymerase gene by marker rescue and cell-free translation of selected RNA. J Virol (1984) 1.61
The involvement of genes 3,4,5 and 6 in genetic recombination in bacteriophage T7. Virology (1975) 1.58
Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription. Mol Cell Biol (1987) 1.55
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
High levels of genetic recombination among cotransfected plasmid DNAs in poxvirus-infected mammalian cells. J Virol (1988) 1.50
Resolution of synthetic Holliday junctions in DNA by an endonuclease activity from calf thymus. EMBO J (1990) 1.47
Promoter melting by a stage-specific vaccinia virus transcription factor is independent of the presence of RNA polymerase. Cell (1991) 1.47
The role of gene 49 in DNA replication and head morphogenesis in bacteriophage T4. J Mol Biol (1971) 1.44
Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases. Nucleic Acids Res (1989) 1.43
Studies on T4-head maturation. 1. Purification and characterization of gene-49-controlled endonuclease. Eur J Biochem (1981) 1.41
Transition of a cloned d(AT)n-d(AT)n tract to a cruciform in vivo. Nucleic Acids Res (1985) 1.41
[Genetic studies with mammalian poxviruses. I. Demonstration of recombination between two strains of vaccina virus]. Virology (1958) 1.40
Delineation of the viral products of recombination in vaccinia virus-infected cells. J Virol (1988) 1.40
High-frequency homologous recombination in vaccinia virus DNA. J Virol (1987) 1.39
Orthopoxvirus genetics. Curr Top Microbiol Immunol (1990) 1.36
Vaccinia virus encapsidates a novel topoisomerase with the properties of a eucaryotic type I enzyme. J Biol Chem (1987) 1.35
Vaccinia virus induces ribonucleotide reductase in primate cells. J Virol (1984) 1.33
Intramolecular homologous recombination in cells infected with temperature-sensitive mutants of vaccinia virus. J Virol (1989) 1.33
Molecular cloning and sequence of the concatemer junction from vaccinia virus replicative DNA. Viral nuclease cleavage sites in cruciform structures. J Mol Biol (1988) 1.33
Some functions involved in bacteriophage T7 genetic recombination. Mol Gen Genet (1974) 1.32
Endonuclease VII resolves Y-junctions in branched DNA in vitro. EMBO J (1986) 1.27
Immunological evidence for the appearance of a new DNA-polymerase in cells infected with vaccinia virus. Virology (1967) 1.24
Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants. J Virol (1988) 1.23
Identification of temperature-sensitive mutants of vaccinia virus that are defective in conversion of concatemeric replicative intermediates to the mature linear DNA genome. J Virol (1989) 1.21
The enzymology of poxvirus DNA replication. Curr Top Microbiol Immunol (1990) 1.17
Physical characterization and molecular cloning of the Shope fibroma virus DNA genome. Virology (1983) 1.16
Single-stranded deoxyribonucleic acid-specific nuclease from vaccinia virus. Purification and characterization. J Biol Chem (1974) 1.14
Fast sedimenting deoxyribonucleic acid in bacteriophage T7-infected cells. Virology (1973) 1.12
Activation of the vaccinia virus nicking-joining enzyme by trypsinization. J Biol Chem (1989) 1.11
A vaccinia virus DNase preparation which cross-links superhelical DNA. J Virol (1985) 1.10
Cruciform cutting endonucleases from Saccharomyces cerevisiae and phage T4 show conserved reactions with branched DNAs. EMBO J (1989) 1.07
Cruciform extrusion in plasmids bearing the replicative intermediate configuration of a poxvirus telomere. J Mol Biol (1987) 1.07
Folded, concatenated genomes as replication intermediates of bacteriophage T7 DNA. J Virol (1977) 1.04
The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter. J Virol (1991) 1.04
Effect of DNA structure and nucleotide sequence on Holliday junction resolution by a Saccharomyces cerevisiae endonuclease. J Mol Biol (1988) 1.04
Transcription of mammalian genes in vitro. Gene Amplif Anal (1981) 1.03
Efficient resolution of replicated poxvirus telomeres to native hairpin structures requires two inverted symmetrical copies of a core target DNA sequence. J Virol (1987) 1.03
The role of the host cell nucleus in vaccinia virus morphogenesis. Virus Res (1987) 1.02
On the role of DNA replication, endonuclease VII, and rII proteins in processing of recombinational intermediates in phage T4. Cold Spring Harb Symp Quant Biol (1984) 1.00
Linkage in the genome of an animal virus. Virology (1959) 1.00
Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping. Nucleic Acids Res (1989) 0.97
Human placental endonuclease cleaves Holliday junctions. Biochem Biophys Res Commun (1988) 0.96
A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution. J Virol (1991) 0.96
The role of telomeres in poxvirus DNA replication. Curr Top Microbiol Immunol (1990) 0.96
Fine structure mapping of five temperature-sensitive mutants in the 22- and 147-kilodalton subunits of vaccinia virus DNA-dependent RNA polymerase. J Virol (1989) 0.95
Resolution of poxvirus telomeres: processing of vaccinia virus concatemer junctions by conservative strand exchange. J Virol (1990) 0.93
Intermediates in genetic recombination of bacteriophage T7 DNA. Biological activity and the roles of gene 3 and gene 5. J Mol Biol (1978) 0.93
Properties of DNA ligase from uninfected and virus-infected HeLa cells. Nucleic Acids Res (1976) 0.91
Resolution of synthetic Holliday structures by an extract of human cells. Nucleic Acids Res (1988) 0.89
Mutations affecting genetic recombination in bacteriophage T4D. II. Genetic properties. Virology (1978) 0.84
The sequence of the human genome. Science (2001) 101.55
Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 4.10
Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction (2000) 3.85
Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron (1990) 3.70
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
The complete DNA sequence of myxoma virus. Virology (1999) 2.44
Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol (1988) 2.40
Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology (1978) 2.09
An adherent dressing for aplasia cutis congenita. Br J Plast Surg (2005) 2.07
Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science (1992) 2.07
Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol (1988) 1.92
Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation (1996) 1.86
Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol (2000) 1.86
Modulating chemokines: more lessons from viruses. Immunol Today (2000) 1.85
Apoptosis: an innate immune response to virus infection. Trends Microbiol (1999) 1.82
Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest (1986) 1.79
Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet (1989) 1.74
Steps towards constructing a global comparative risk analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res (2001) 1.73
The complete genome sequence of shope (rabbit) fibroma virus. Virology (1999) 1.73
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72
Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells. Proc Natl Acad Sci U S A (1986) 1.71
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA (1999) 1.70
T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun (1991) 1.64
Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology (1995) 1.64
Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J Virol (1992) 1.59
Mechanisms of hypoxemia during panendoscopy. J Clin Gastroenterol (1989) 1.54
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
The site-specific cleavage of synthetic Holliday junction analogs and related branched DNA structures by bacteriophage T7 endonuclease I. J Biol Chem (1987) 1.52
High levels of genetic recombination among cotransfected plasmid DNAs in poxvirus-infected mammalian cells. J Virol (1988) 1.50
SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology (1993) 1.49
A poxvirus-encoded uracil DNA glycosylase is essential for virus viability. J Virol (1993) 1.45
Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease. Nephron Clin Pract (2004) 1.45
Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem (2000) 1.44
Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory. Schizophr Res (2000) 1.44
Use of chemokine receptors by poxviruses. Science (1999) 1.43
The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol (1997) 1.43
Bronchial stent placement in a dog with bronchomalacia and left atrial enlargement. J Small Anim Pract (2014) 1.40
Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology (1991) 1.40
M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med (2000) 1.39
Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology (1991) 1.39
Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology (1990) 1.38
Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol (1996) 1.37
Search for neutrinoless double-beta decay in 136Xe with EXO-200. Phys Rev Lett (2012) 1.33
Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J Virol (2005) 1.33
Biogenesis of poxviruses: mirror-image deletions in vaccinia virus DNA. Cell (1979) 1.30
Idiopathic hypoparathyroidism: a cause of fits in the elderly. Br Med J (1979) 1.30
Immunomodulation by viruses: the myxoma virus story. Immunol Rev (1999) 1.28
Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc Natl Acad Sci U S A (1996) 1.27
Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology (1996) 1.27
Identification of a poxvirus gene encoding a uracil DNA glycosylase. Proc Natl Acad Sci U S A (1993) 1.25
Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability. J Virol (1996) 1.25
Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology (1996) 1.24
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells. Leukemia (2009) 1.22
Mechanism of replication of phi x174 single-stranded DNA. IX. Requirement for the Escherichia coli dnaG protein. J Virol (1974) 1.21
Identification and DNA sequence of the large subunit of the capping enzyme from Shope fibroma virus. Virology (1991) 1.19
The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Mol Cell Biol (1987) 1.19
Day hospitals in modern clinical practice--cost benefit. Age Ageing (1979) 1.19
Aggression and barroom environments. J Stud Alcohol (1980) 1.18
Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J Virol (1987) 1.16
Physical characterization and molecular cloning of the Shope fibroma virus DNA genome. Virology (1983) 1.16
Tumorigenic poxviruses: analysis of viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus. Virology (1986) 1.16
Immunomodulatory proteins of myxoma virus. Semin Immunol (2001) 1.14
Interruption of cytokine networks by poxviruses: lessons from myxoma virus. J Leukoc Biol (1995) 1.13
New strategies of immune modulation by DNA viruses. Transplant Proc (1996) 1.12
Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. Circulation (1988) 1.12
The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest (2000) 1.12
Alcohol-related aggression in the general population. J Stud Alcohol (2000) 1.10
Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus. J Virol (1986) 1.09
Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology (1987) 1.09
Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood (2001) 1.08
Identifying and measuring alcohol abuse among the elderly: serious problems with existing instrumentation. J Stud Alcohol (1986) 1.08
Cruciform extrusion in plasmids bearing the replicative intermediate configuration of a poxvirus telomere. J Mol Biol (1987) 1.07
The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. J Biol Chem (1995) 1.07
Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology (1998) 1.06
Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem (1993) 1.06
Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit. Eur J Paediatr Neurol (2011) 1.06
The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology (1997) 1.06
Biogenesis of poxviruses: role for the DNA-dependent RNA polymerase II of the host during expression of late functions. Proc Natl Acad Sci U S A (1979) 1.05
A pilot study of the liposomal MUC1 vaccine BLP25 in prostate specific antigen failures after radical prostatectomy. J Urol (2006) 1.04
The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter. J Virol (1991) 1.04
Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology (1992) 1.04
The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-alpha in a species-specific fashion. Virology (1994) 1.03
Efficient resolution of replicated poxvirus telomeres to native hairpin structures requires two inverted symmetrical copies of a core target DNA sequence. J Virol (1987) 1.03
Biogenesis of poxviruses: preliminary characterization of conditional lethal mutants of vaccinia virus defective in DNA synthesis. Virology (1980) 1.02
Cloning and sequencing of the cytoplasmic precursor to the alpha subunit of rat liver mitochondrial succinyl-CoA synthetase. Proc Natl Acad Sci U S A (1988) 1.02
Analysis of linkage between scrapie incubation period and the prion protein gene in mice. J Gen Virol (1990) 1.02
Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1. Oncogene (2010) 1.02
High- or low- technology measurements of energy expenditure in clinical gait analysis? Dev Med Child Neurol (1999) 1.02
Optical detection of triggered atherosclerotic plaque disruption by fluorescence emission analysis. Photochem Photobiol (2000) 1.01
Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1. J Biol Chem (1998) 1.01
Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc Natl Acad Sci U S A (2001) 1.01
Tumorigenic poxviruses: genomic organization of malignant rabbit virus, a recombinant between Shope fibroma virus and myxoma virus. Virology (1985) 1.01